NCT07637448
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Southern Medical University Nanfang Hospital Department of Oncology Guangzhou, Guangdong, China
Clinical trial condition
PD-1 Antibody
Explore clinical trials studying PD-1 Antibody. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
PD-1 Antibody trial results
NCT05554276
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Vitalbeam Shanghai, China
Not Yet Recruiting
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
NCT05775705
- Conditions
- DNA Virus Infections, Epstein-Barr Virus, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
Completed
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
NCT04834674
- Conditions
- Adenocarcinoma, Apatinib, Carcinoma, +7 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
NCT04507217
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
- Locations
-
- Cancer Center of Sun-Yat Sen University (CCSYSU) Guangzhou, Guangdong, China
- Guangxi Medical University Affiliated Tumor Hospital Nanning, China